Gentronix has been granted a research award, which is to fund a
potentially viable alternative to animal testing, reducing the need
for their use during drug development.
IDBS and In Silico Discovery have announced the formation of a
partnership in which the deal aims to integrate drug discovery data
and providing flexible access irrespective of where it is stored.
A new ethics report has raised concerns about using animal-human
embryonic hybrids in drug testing in which the creation of these
chimeras are creating exciting avenues of research as well as
controversy.
A new service introduced on the back of customer demand has been
launched by Aviva Systems Biology which make available a method for
genome-wide detection of promoters and enhancers that interact with
proteins or carry modifications.
A new finding has the potential to pave the way for better
treatment options for autoimmune diseases as researchers discover a
signalling molecule can yield a rapid, inexpensive way to make
large numbers of immune cells.
In their hunt for DNA that is amplified in cancers, researchers
have discovered a new cancer-promoting role for a gene that has
been shown to transform mammary epithelial cells into cancerous
ones.
Nanogen and Fisher Scientific have announced an expansion to their
relationship to include a research and development collaboration in
molecular diagnostics. The collaboration agreement complements
Fisher's equity investment...
Thermo has released an enhanced version of its Heraeus Pico & Fresco microcentrifuges that have been designed to cover a broad spectrum of life science research areas including drug discovery.
Researchers believe that a genetic discovery involving a cellular
signal that aggravates the symptoms of MS may be a viable target in
new therapeutic approaches, which could alleviate the burden of
this debilitating neurological disease.
GlaxoSmithKline (GSK) has decided to outsource its research in
genotyping by awarding a contract to Expression Analysis who will
provide the pharma giants with microarray-based genotyping
services.
Researchers have identified a gene that plays a pivotal role in
initiating two DNA damage detection and repair pathways in the
human genome, suggesting that it functions as a tumour suppressor.
Drug researchers have turned to an unusual source to boost the
efficacy of a particular anticancer drug by investigating the
properties of a mushroom that has been used for centuries in
Eastern Asian medicine.
SuperArray Bioscience has made available a range of pathway-focused
real-time PCR gene panels that allow scientists to use their
real-time PCR instrument just like a microarray in the multiple
stages involved in drug discovery and...
Aldevron has announced the expansion of its Genetic Immunisation
and Antibody (GIA) facility to meet the increased demand of vaccine
screening contracts.
CHDI and Edison Pharmaceuticals have entered into alliance that
looks to develop effective therapeutics in targeting Huntingdon's
disease - a disorder that currently has no way to stop or reverse
the its progression.
Predix Phamaceuticals has formed a collaboration with Amgen in a
deal that aims to develop S1P1 modulators for the treatment of
autoimmune diseases. The agreement has the potential to become a
$300m (€235m) payout for Predix.
Chimatica makes available its range of pre-selected,
target-specific screening compounds that provide new chemotypes and
opportunities for accelerated lead identification and further
optimisation.
UK government legislation designed to curb animal extremism appears
to be working as statistics published this week records a reduction
in the number of incidents provoked by animal rights extremists
during the first half of this...
Murex Pharmaceuticals has licensed Ariadne's software solution,
which is to play a vital role in the visualisation and analysis of
biological pathways and gene regulation networks for cancer
therapeutics development.
Researchers have taken a special interest in mechanisms they have
identified as an explanation for the causes of Parkinson's disease,
which they say, may facilitate research aimed at finding novel
medical treatments and other...
The insulin market is set to explode over the next five years as
uptake of insulin therapy is likely to increase with sufferers
benefiting from heightened awareness and knowledge as well as the
influx of affordable, innovative product...
Genentech and Inotek have entered into a strategic alliance in
which they will concentrate on the discovery, development and
commercialisation of PARP inhibitors for cancer - a class of drug
that has demonstrated high efficacy in...
Locus Pharmaceuticals is to initiate Phase I trials of a novel
anticancer drug that could prove effective against drug resistant
tumours after the small molecule cleared the 30-day review period
by the FDA for its Investigational...
Celera Genomics announces its new test that is used for genotyping
of the hepatitis C virus (HCV) has obtained regulatory approval for
commercial sale in Europe, signifying the first real-time test for
genotyping the HCV virus to...
A new concept to develop a more accurate method for rapidly
screening chemical compounds has been unveiled, which the
researchers say will significantly aid in identifying leads for
drug development and discovery.
Researchers in the US have developed an exciting new tool that
enables scientists to watch cell chemical activity in real-time.
The tool's development has major implications for speeding up new
drug design.
MedImmune and Micromet have provided details on a novel drug
molecule that targets a tyrosine kinase receptor that is frequently
overexpressed on solid tumours and provides the opportunity to
develop an anti-cancer therapeutic, which...
Alnylam has been issued a US patent, which protects its method of
making small interfering RNAs with and without chemical
modifications, which is set to have far reaching implications in
future drug discovery.
According to the results of a new survey HIV patients are in the
dark about treatment options and the significance of drug
resistance, not only jeopardising their own health but also
potentially exacerbating the problem of limited...
A team of scientists believe that a worm can help to discover new
drugs by genetically modification allowing the worm to distinguish
harmful chemicals to those with therapeutic benefit.
Agilent Technologies has introduced its new microarray that offers
high-resolution genomic coverage, whilst enabling multiple
experiments per slide. The technology has the potential to make
savings both in time and cost.
Galapagos and Cellzome have announced the start of a drug discovery
collaboration in which the two companies are to concentrate on
kinases, a popular target for pharmaceutical therapies for cancer
and inflammatory diseases.
According to a new report the proteomic revolution and the
emergence of the customised drug market has led to an increased
demand for mass spectrometers in the US, driving strong growth over
the next seven years.
There's welcome relief for haemorrhoid sufferers after researchers
identified the existence of an enzyme that could be key to treating
chronic and severe disorders such as certain forms of constipation,
anal fissures and Hirschsprung's...
A unique approach to drug development could be on the horizon after
researchers utilised a method to crystallise proteins that would
allow better examination of proteins, leading to the production of
targeted drugs.
Neuropharma has developed a new treatment for Alzheimer's Disease,
which uses a unique method of attack, incorporating a mechanism of
action that targets a little-known enzyme that contributes to the
proliferation of the neurodegenerative...
Torey Pines Scientific has announced the launch if its new stirring
hot plate, which has been designed for use in the chemical,
pharmaceutical, biochemical, and laboratories where reproducible,
accurate, hands-off sample preparation...
Companies in the healthcare sector, including drug discovery
technologies, healthcare and life sciences IT, and medical devices
were out in force this week at Frost & Sullivan's 2006
Excellence in Healthcare Awards
Ohaus make available its new series of semi-micro and analytical
balances specifically designed for applications that require
precise measurement in the pharmaceutical research, drug discovery,
and general lab application arena.
A once-a-day pill to treat HIV that combines three drugs has been
given the green light by the US Food and Drug Administration (FDA)
in a response to patients' increasing demands for convenient
combined treatments.
Procter & Gamble Pharmaceuticals and ARYx Therapeutics have
formed a partnership, which aims to take drug treatments for
gastrointestinal disorders to the next level with their novel drug
candidate
A new computational program has been developed by US researchers
that uses computational systems biology to better understand the
biochemical networks that regulate the interactions between
infectious organisms and the human or animal...
Thermo Electron introduces its solution for researchers involved in
large volume pipetting, making available a pipetting aid that
incorporates a motor to allow faster pipetting of volumes saving
time and cost without compromising...
Chemicon are to supply drug targets for MorphoSys in a licensing
agreement that will see MorphoSys develop antibodies from its
proprietary HuCAL Gold antibody library.
Locus Pharmaceuticals has announced it has entered a drug discovery
agreement with Ono Pharmaceuticals in a deal that will focus on
protein kinases as a molecular target.
Wyeth has announced that it has selected NovaScreen to conduct a
high-throughput screening (HTS) campaign, which makes use of
Caliper's microfluidic screening platform, which utilises
reproducible electrophoretic separation of...
A cancer biology discovery could lead to new diabetes treatments
after it was discovered that a mutation in a tumour suppressor gene
causes pancreatic islet cells to reproduce.
Isotechnika has received an additional US patent for its lead
immunosuppressive drug, which is the first patent to be issued in
this patent family in the US. The lead compound has demonstrated
encouraging results in recent Phase II...
Dynal has announced today the release of a new research tool in its
immunotherapy range that allow researchers to isolate and collect T
cells from immunocompromised patients for ex vivo stimulation and
expansion in a sterile environment.
The PiperJaffray conference gave biopharmaceutical company Speedel
ample opportunity to inform investors of its intentions for 2006
and beyond. The company have just released promising data on a new
first-in-class diabetic treatment.